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Abstract
HIV testing uptake continues to be low among Female Sex Workers (FSWs). We synthesizes evidence on barriers and facili-
tators to HIV testing among FSW as well as frequencies of testing, willingness to test, and return rates to collect results. We 
systematically searched the MEDLINE/PubMed, EMBASE, SCOPUS databases for articles published in English between 
January 2000 and November 2017. Out of 5036 references screened, we retained 36 papers. The two barriers to HIV testing 
most commonly reported were financial and time costs—including low income, transportation costs, time constraints, and 
formal/informal payments—as well as the stigma and discrimination ascribed to HIV positive people and sex workers. Social 
support facilitated testing with consistently higher uptake amongst married FSWs and women who were encouraged to test 
by peers and managers. The consistent finding that social support facilitated HIV testing calls for its inclusion into current 
HIV testing strategies addressed at FSW.
Keywords HIV diagnosis · HIV testing · Female sex workers (FSWs) · Systematic review
Resumen
La aceptación a realizar las pruebas de VIH continúa siendo baja entre las Mujeres Trabajadoras Sexuales (MTS). Nosotros 
sintetizamos evidencias sobre las barreras y las facilidades para realizar las pruebas de VIH entre las MTS, así como sobre 
las frecuencias de la prueba, voluntad de evaluar y tasa de retorno para recoger los resultados. Se realizaron búsquedas sis-
temáticas en las bases de datos MEDLINE/PubMed, EMBASE,SCOPUS para artículos publicados en inglés entre enero del 
2000 y noviembre de 2017. De 5036 referencias examinadas, elegimos 36 artículos. Las dos barreras más comunes para las 
pruebas de VIH fueron los costos financieros y de tiempo, incluyendo: bajos ingresos, costos de transporte, limitaciones de 
tiempo y pagos formales/informales, así como el estigma y la discriminación atribuidos a las personas y trabajadoras sexuales 
seropositivas. El apoyo social facilitó las pruebas de VIH con una mayor aceptación entre las MTS casadas y las mujeres 
a quienes sus compañeros y gerentes les animaron a realizarlas. El hallazgo consistente en que el apoyo social facilitó las 
pruebas de VIH requiere su inclusión en las estrategias actuales de pruebas de VIH realizadas en MTS.
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Introduction
Worldwide, early HIV testing is a public health priority 
especially among key populations such as female sex work-
ers (FSWs) [1–3]: out of the estimated 33 million people 
living with HIV in the world, 19 million do not know their 
status [1]. Early HIV diagnosis has gained significant atten-
tion within key global health institutions, including the Joint 
United Nations Program on HIV/AIDS (UNAIDS) and the 
recently established 90-90-90 targets [4]. It is proposed that 
by 2020, 90% of all people living with HIV should know 
their HIV status, 90% of all people with diagnosed HIV 
should receive sustained antiretroviral treatment, and 90% 
of all people receiving antiretroviral treatment should reach 
viral suppression [4]. Historically, HIV prevention efforts 
focused on key populations, including sex workers, as an 
effective approach to reduce HIV transmission, particularly 
in the early phase of the epidemic [5].
Several systematic reviews have examined HIV preva-
lence [6–8] and effectiveness of different HIV prevention 
interventions for SWs [9–12]. Shahmanesh et al. presented 
evidence for the efficacy of multi-component interventions, 
and⁄or structural interventions [9]. A Cochrane review of 
behavioral interventions concluded that, compared with 
standard care or no intervention, behavioral interventions are 
effective in reducing HIV and the incidence of STIs amongst 
FSWs [10]. A systematic review of community empower-
ment interventions in low- and middle-income countries 
demonstrated significant protective combined effect for HIV 
infection (prevalence), STIs such as gonorrhea and chla-
mydia, and increase of consistent condom use with all cli-
ents [12]. A systematic review of community empowerment 
interventions in generalized and concentrated epidemics has 
shown their positive impact on HIV prevalence, estimated 
number of averted infections among SWs and adult popula-
tion, and expanded coverage of ART [11]. These previous 
studies did not systematically assess HIV testing approaches, 
but rather examined the combined effect of a variety of pre-
vention activities. Thus, they failed to address unique deter-
minants of different HIV testing approaches.
HIV testing activities among sex workers were assessed 
in only two papers including a meta-analysis of community-
based approaches [13], and a study of barriers to HIV test-
ing in Europe [14]. According to these studies, community-
based HIV testing leads to higher HIV testing rates than 
facility-based testing, and the most common barriers to HIV 
testing are low-risk perception, fear and worries, poor acces-
sibility to healthcare services, health providers’ reluctance to 
offer the test, and scarcity of financial and human resources. 
Still, neither of those studies focused on FSWs nor system-
atically reviewed unique facilitators and barriers to HIV 
testing faced by this group. The present review compiles 
existing evidence on HIV testing among FSWs in order to 
better meet the needs of this group while implementing the 
first target of the 90-90-90 strategy. Our specific objectives 
are: (1) to summarize data on key barriers and facilitators to 
HIV testing among FSWs, and (2) to systematically review 
frequencies of testing, willingness to test, and return rates 
to collect HIV test results in this population.
Methods
We applied a free text strategy and MeSH terms to system-
atically scan the electronic databases MEDLINE/PubMed 
using the platform OVID, and EMBASE and SCOPUS. We 
employed a combination of terms that covered the concepts 
‘HIV’, ‘Sex work’ and ‘Test’. We conducted several scop-
ing searches to identify the most efficient search strategy, 
which we provide in “Annex 1: Search strategy”. Guidelines, 
reports and policy documents were searched using Google 
Scholar and employed to inform the discussion of findings. 
We exported all identified references (5036) into the biblio-
graphic management software ENDNOTE X7.
The first author (AT) screened titles and abstracts 
against the following inclusion criteria: (1) published in a 
peer-reviewed journal between January 2000 and Novem-
ber 2017; (2) written in English; and (3) presenting data 
on HIV testing among FSWs. We excluded duplicates 
and studies for which no abstract or full text was available 
(N = 17). After reviewing the full text of 95 pre-selected 
articles against the above mentioned inclusion criteria, 36 
papers were retained for a more detailed review. The first 
author extracted data systematically using a standardized 
form that included information on the period of study, loca-
tion, study population, design, research questions, key find-
ings, and conclusions (“Annex 2: Data extraction form”). 
Next the quality of qualitative papers was assessed using 
the guide for critically appraising qualitative research by 
Spencer et al. [15]. The modified Downs and Black check-
list was applied to quantitative and mixed-methods papers 
[16]. We used a midpoint score of 9 for qualitative papers 
and 12.5 for quantitative ones as a cut off between low- and 
high-quality studies. Overall, two quantitative papers with 
score of 10 [18] and 9 [17] points failed to meet the criteria; 
three papers received 12 points [19, 20]. The vast majority 
of quantitative papers lacked information needed for assess-
ment. We were unable to appraise four abstracts: three, for 
the limited data presented, and one, being a mathematical 
modeling paper [21] that did not fit well with the quality 
appraisal tools employed. We decided to include all papers 
into the review in order to provide a comprehensive picture; 
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at the same time, we considered it important to stress the 
results of the quality assessment (“Annex 3: Quality assess-
ment”). The results of the search and screening process are 
described in Fig. 1.
Guided by the socio-ecological model (SEM) developed 
by Blanchard et al. [22] we classified data into three lev-
els: macro-, meso-, and micro-level factors (Table 1). The 
macro level consisted of economic and policy factors. The 
meso level included social networks, organizations, cultural 
norms, and values. The micro level included individual 
socio-demographic characteristics, knowledge, risk aware-
ness, and behavioral factors. We also extracted data on pre-
vious experiences of HIV testing and ways to encourage 
uptake. The PRISMA check list is provided as “Annex 4: 
PRISMA 2009 Checklist”.
Results
Out of the 36 studies retained for review, most were quantita-
tive (N = 20) and conducted in Asia (N = 18). Nine papers 
reported work conducted in Africa, three in Europe, three in 
Russia, and one in Macedonia. Three studies were conducted 
in Latin America, two in Canada and one in Australia. Eight-
een studies were cross-sectional, and twenty-five focused 
exclusively on FSWs.
Previous Experience of HIV Testing
We summarized evidence on previous experience of HIV 
testing and approaches to facilitate testing (Table 1). Fifteen 
studies [17, 18, 23–35] focused on ever in life testing. The 
highest rate was reported in a study in Russia where all 
recruited FSWs (100%, N = 29) were tested [24] followed by 
Kenya (88.6%, N = 818) [27]. The lowest rate was reported 
in a study conducted in India (7.9%, N = 6648) [18]. Ten 
studies examined recent testing [25, 27–29, 35–40], which 
varied extensively from 76.1% in Canada (N = 435) [25] to 
22% in China (N = 970) [38]. Six studies addressed willing-
ness to test [18–20, 28, 41, 42], and this ranged from 88% 
(N = 17) in China [41] to 73.2% in India (N = 6648) [18]. 
Three studies reported that willingness facilitated actual HIV 
testing [20, 28, 41]. Only four studies assessed frequencies 
of collecting test results [23, 26, 33, 43], and these ranged 
widely from 92.3% in Guinea [26] to 14.8% in Thailand [43].
We identified a high variability of outcome measures 
employed in the studies reviewed. For example, the fre-
quency of HIV testing was measured using different time 
frames and included “last month” and “recent testing” with 
a time period corresponding to “recent” that varied from 
1 year to 1 month.
Conceptual Framework: Barriers and Facilitators 
of HIV Testing Amongst FSWs
In this study we employed an adapted version of the socio-
ecological framework developed by Blanchard et al. [22] to 
organize and analyze our findings systematically. As shown 
in Fig. 2, we conceptualized HIV test uptake as the result of 
a number of interrelated factors that operate simultaneously 
at the micro, meso and macro levels. Most articles focused 
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on the micro (N = 30) and meso (N = 24) levels, and about 
half of all papers addressed the macro (N = 19) level. Ten 
studies analyzed concurrently two levels of the social ecol-
ogy, while nine addressed simultaneously the micro, meso, 
and macro levels.
Micro‑level Factors
Socio Demographic Characteristics
Sixteen articles focused on socio-demographic character-
istics. We found no consistent associations [18, 27, 31, 32, 
44–46] of education and age [23, 31, 45] with HIV test-
ing uptake. Highly educated women in the Philippines and 
Iran were more likely to test [39, 45], but studies in China 
reported higher HIV testing uptake amongst women with 
both high [23] and low education level [31]. In two studies 
conducted in China and one in the Philippines, older age 
facilitated HIV testing [31, 44, 45], but in Russia, Ethiopia 
and Kenya older-aged FSWs [46, 47] and those aged + 30 
[27] were less likely to test compared to younger FSWs. In 
Uzbekistan and India, younger age decreased testing [18, 
32]. Higher income was associated with testing in India 
and the Philippines [18, 45] and in Russia poverty impeded 
access to healthcare, including HIV testing [24].
Ten studies reported that having children and/or being 
pregnant and/or being in a permanent relationship facilitated 
HIV testing [19, 23, 27, 28, 30, 34, 45, 47–49]. Married 
women in China [19] and those with a regular sexual partner 
in the Philippines [45] and in China [23] were more likely 
to test. According to a study conducted in Vietnam, unmar-
ried women were less likely to test [30]. In Kenya, Zambia, 
Benin, Ethiopia, Russia and India, having children or being 
pregnant facilitated HIV testing [27, 28, 34, 47–49]. In Iran, 
incarceration was associated with recent testing [39].
In Canada and Benin, migrant FSWs [25, 29] had limited 
access to healthcare because of language barriers, which led 
to low HIV testing rates.
MACRO LEVEL 
HIV testing policies: mandatory testing, forced testing, non-anonymous testing, lack of confidentiality, guarantee 
retention to treatment                                                                                                         
Health care funding: health care entitlements, free ART, formal and informal payments.
Criminalization: criminalization of sex work/drug use. 
MESO LEVEL 
Sex work venue: level of income generated by sex work venues, indoors/outdoors. 
Social network: support and attitude of peers, sex work managers, family.                                               
Stigma and discrimination: fear of being identified as HIV+, fear of imprisonment if testing HIV+, fear 
to disclose history of sex work/drug use, discrimination from health care providers, discrimination from 
family members, self-stigmatization, negative perceptions about the quality of health care.  
Costs (transport and time): time constraints, density of HIV testing sites, travel costs to collect results.         
MICRO LEVEL 
Socio-demographic characteristics: education, age, income level, family status, migration status.
Risk behaviors: type and number of sexual partners, condom use, age at sex work initiation and 
period of engagement in sex work, drug and alcohol use. 
Risk awareness: perceived personal risk of HIV infection, perception about HIV prevalence 
HIV related knowledge: knowledge about HIV and available testing services.                                     
Access to HIV 
testing 
Willingness to 
test 
Collecting test 
results 
Regularity of 
HIV testing 
Fig. 2  Conceptual framework: barriers and facilitators of HIV testing amongst FSWs. Reproduced with Permission from Blanchard et al. [22]
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Risk Behaviors
Seven studies reported nearly inconsistent patterns on how 
regular condom use influenced HIV testing. Using condoms 
during every instance of each sexual intercourse both facili-
tated and impeded testing depending on the type of sexual 
partner [19, 20, 25, 31, 33, 39, 41]. Three articles reported 
that inconsistent condom use with a client -facilitated test-
ing [25, 31, 33], but using condoms inconsistently with a 
husband or lover was negatively associated with testing [33]. 
In China, a quantitative study identified that condom use 
was associated with HIV testing [20], although in a previ-
ous qualitative study the same author found that FSWs who 
used condoms consistently felt to be sufficiently protected 
from HIV and not in need of testing [41]. In Iran, consistent 
condom use during each sexual intercourse was associated 
with recent testing [39].
Initiation of sex work at an older age [18, 20, 33, 35, 45] 
and engaging in sex work for a longer period of time [18, 20, 
33, 45] facilitated HIV testing. In Uzbekistan, FSWs who 
started sex work before the age of 18 were less likely to test 
[32], and in Canada older age of sex work initiation was 
positively associated with recent testing [25]. FSWs who 
engaged in sex work for a longer time had a higher uptake 
of testing [18, 20, 33, 45] and willingness to test [19]. FSWs 
employed for shorter periods [27, 32] were less likely to test.
Having a lower number of clients/sexual partners was 
associated with HIV testing in China [23], but was reported 
to decrease testing in Vietnam [30], Iran [39] and Uzbeki-
stan [32].
Most studies identified drug use and alcohol consumption 
to impede HIV testing [24, 25, 27, 32–34, 46]. Still, in Iran 
and Canada drug use among FSWs did not hinder testing 
[25, 35].
Risk Awareness
We reviewed thirteen articles that focused on individual 
perceptions towards HIV risks [19, 20, 23, 26, 31, 33–35, 
39, 41, 45, 47, 50]. Low perceived risk was associated with 
lower likelihood to test [31, 45, 47], and FSWs would be 
less likely to test if they believed that HIV prevalence to be 
decreasing and no one in their social network was infected 
[41]. Conversely, high perceived risk was associated with 
HIV testing [19, 23, 26, 33–35, 39, 41, 45, 50].
HIV‑Related Knowledge
Seventeen articles examined HIV knowledge, including 
knowledge of available HIV testing sites in the area [19, 29, 
31, 33–36, 38–41, 45, 47–51]. FSWs who had heard preven-
tion messages in HIV communication campaigns were more 
likely to test [33, 47, 51]. Similarly, FSWs were reluctant to 
test if they had poor HIV-related knowledge [29, 36, 41, 48, 
49, 51] and were not well informed about local testing sites 
[31, 41, 48, 50–52].
Meso‑level Factors
Sex Work Venue
Of the six articles that addressed sex work venues [18, 25, 
31, 41, 45, 50], most reported that working indoors and at 
high-income venues generating higher income impelled HIV 
testing. Working in a high-income venue and out of the street 
predicted testing in China, Vietnam and India [18, 31, 50]. 
However, in Canada, FSWs working indoors were less likely 
to have recently tested for HIV than those working outdoors 
[25].
Social Support
About half of the articles reviewed assessed how FSWs’ 
social interactions influenced their decision to test for HIV 
[18–20, 24, 26, 29, 34, 38, 40, 41, 43, 45, 47–51]. Posi-
tive attitudes and support from peers, family and partners 
facilitated HIV testing [19, 20, 24, 26, 29, 34, 40, 41, 45, 
48–51]. In China, women were more likely to test if accom-
panied by peers [19, 20]. In Russia, family support was an 
important condition for accessing healthcare, including HIV 
testing, as women could rely on their family financially and 
emotionally [24]. Participation in self-support groups in 
India [18] and Uganda [51] and receiving condoms from 
HIV prevention programs in China [38] facilitated testing. 
Positive views of FSWs’ employers towards HIV testing [41, 
45] or requiring the test [43, 50] increased the uptake. How-
ever, in China and Ethiopia, employers expressed concerns 
towards HIV testing and how it could impact the sex work 
business [41, 47]. In Guinea, HIV testing was forbidden by 
some managers [26]. In Zambia and Russia, fear of negative 
reaction of their sexual partner if diagnosed HIV-positive, 
prevented women from engaging in HIV testing [34, 49].
Stigma and Discrimination
A total of fourteen articles focused on stigma and discrimi-
nation of HIV+ people and/or sex workers [20, 24, 26, 29, 
31, 34, 36, 41, 46–52]. Fears of being identified as HIV+ 
[24, 26, 31, 34, 36, 41, 47–51] or as a sex worker [20, 26, 
31, 34, 41, 46–52] were reported as barriers to testing in a 
number of studies. FSWs could refuse HIV testing [29, 36, 
41, 48, 50, 52] or fail to collect test results [48] if afraid of 
receiving an HIV+ diagnosis.
In Benin, healthcare workers reported that women did 
not like to be recognized as FSWs, and that this could pre-
vent them from seeking healthcare [29]. In several African 
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countries, health providers discriminated against sex work-
ers and their family members [52]. In Russia, FSWs were 
concerned that they would be treated badly or denied health-
care if identified as sex workers or drug users [46]. In China, 
FSWs worried about meeting an acquaintance at the testing 
site and being recognized as HIV+ [41], while in Vietnam, 
they feared imprisonment if diagnosed with HIV [50]. Self-
stigma resulting from widespread negative views of HIV+ 
people and sex work decreased testing across several Afri-
can countries [52]. Thirteen articles reported that anticipated 
stigma and discrimination at health facilities hampered ser-
vice utilization [19, 20, 24, 26, 29, 37, 41, 46, 48–52]. In 
Russia, Vietnam, Uganda and several African countries, 
private hospitals were defined by FSWs as more friendly 
and of higher quality than public health facilities, and were 
reported to be preferable places to get healthcare services, 
including HIV testing [24, 50–52].
Time and Transport Costs
Eleven articles reported that time and transport costs ham-
pered access to healthcare [24, 31, 34, 36, 37, 41, 43, 47, 
49–52]. Time restraints impeded testing in China [31, 41], 
India [48], Thailand [43], Vietnam [50], Uganda [51], Zam-
bia [49], Ethiopia [47] and several other African countries 
(Kenya, Zimbabwe, Uganda and South Africa) [52]. In 
Uganda, Zambia and Russia, FSWs expressed dissatisfac-
tion with opening hours of health facilities as they did not 
correspond with women’s schedules and caused financial 
and time loss [34, 49, 51]. In Canada, higher density of test-
ing sites and little time needed to get there were associated 
with having tested recently [37]. In Thailand, travel costs 
were reported to prevent users from collecting their HIV 
test results [43].
Macro Level Factors
HIV Testing Policies
Eleven articles focused on HIV testing policies [21, 24, 
32, 34, 41, 46–48, 50–52] pointed to shortcomings in the 
range of services that should be provided together with HIV 
testing. These include informed Consent, Confidentiality, 
Counseling, Correct test results, and Connection to care and 
treatment, known as the “5 Cs” principles [3].
In China [41], Vietnam [50], India [48], Uganda [51], 
Zambia [49], Ethiopia [47] and Russia [46], lack of con-
fidentiality was reported as a major barrier to HIV testing. 
Unwillingness to be included in official registers of HIV+ 
people decreased access to testing in China [41] and Russia 
[24]. In Russia, FSWs without a residence permit or passport 
are not entitled to accessing healthcare. Free-of-charge HIV 
testing is available only upon giving up anonymity, and if a 
woman utilizes state-sponsored HIV testing at a local clinic, 
the results are officially recorded into her personal medical 
records [24]. In India and Ethiopia, to access HIV and AIDS 
treatment, women are required to show an identity card [47, 
48]. In Uganda, all women diagnosed HIV positive were 
given two papers indicating test result and further referrals 
while all diagnosed HIV negative were given one paper with 
test result only [51].
FSWs were forced to test against their will or were tested 
surreptitiously without consent in Kampala (Uganda), Hill-
brow and Limpopo (South Africa) [52] and during police 
detainment in Uzbekistan [32] and Macedonia [53]. In Viet-
nam, among the FSWs who tested for HIV, only 54% did it 
voluntarily [33]. FSWs who had spent time in rehabilitation 
or detention centers [24, 30, 50] or had ever been pregnant 
[24, 50] were more likely to have undergone HIV testing. In 
Victoria, Australia, screening of sex workers is mandatory 
despite its lack of cost-effectiveness [21].
Healthcare Funding
Eleven articles reported how limited healthcare fund-
ing decreased HIV testing [19, 20, 24, 26, 32, 36, 41, 48, 
50–52]. High medical care costs in China [41], Iran [36], 
several African countries (Kenya, Zimbabwe, Uganda and 
South Africa) [52] and informal payments in Russia [24], 
Uganda [51] and India [48] reduced access to healthcare, 
including testing. Five articles suggested that free treatment 
might increase testing [19, 20, 26, 47, 50].
Criminalization
Eight studies reported how current criminalized approaches 
to sex work and drug use inhibited FSWs from accessing 
healthcare [24, 25, 27, 32, 34, 51, 52, 54]. Sex work crimi-
nalization in Kenya, Zimbabwe, Uganda and South Africa, 
Canada, Uzbekistan and Russia [24, 25, 27, 32, 51, 52, 54] 
and fear of registration as a drug-user in Russia [24, 34] 
are seen to have hampered access to healthcare, including 
testing.
Testing Modalities
A total of twenty studies examined different ways to encour-
age HIV testing among FSWs including self-testing [39, 
54], home-based [25, 29, 42], rapid testing [35, 43], work-
based [29], oral fluid tests [42], “friendly cabinets” (newly 
established anonymous testing centers) at public STI clin-
ics [32, 51], mobile services [43], outreach with referrals 
[24, 34, 39], community mobilization [29, 52], community 
empowerment [49] and involvement of peers, managers and 
healthcare workers [19, 20, 39, 45, 47, 49–52]. In one study 
examining hypothetical circumstances around self-testing, 
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participants reported to anticipate significant benefits (entire 
privacy, avoiding travel and time costs, ability to test before 
sex early diagnosis), although these same features raised 
concerns when associated with lack of supportive counseling 
and linkage to care [54].
These studies suggest that HIV testing might increase 
if FSWs can easily access testing sites and receive support 
from peers, friends and healthcare workers along with edu-
cational activities [19, 20, 45, 50–52].
Discussion
This systematic review of barriers and facilitators to HIV 
testing amongst FSWs found that the two barriers to HIV 
testing most commonly reported are (1) costs, including 
transportation, formal/informal payments, and time, and 
(2) stigma, including fear of involuntary disclosure of HIV 
status/history of sex work, negative attitudes of healthcare 
workers, and discriminatory policies. Social support facili-
tated HIV testing, with consistently higher uptake amongst 
married FSWs, and those encouraged to test by peers, 
healthcare workers or employers.
The majority of the studies reviewed were conducted in 
low and middle-income countries with only three studies 
identified in high-income settings. Only one study evaluated 
the cost-effectiveness of HIV testing amongst FSWs. Most 
studies addressed micro, or micro and meso levels of the 
SEM with predominance of micro-level factors. Thirteen 
studies analyzed concurrently the macro, meso and micro 
levels. Our findings support previous calls to develop HIV 
testing strategies that fully account for structural factors [55, 
56] and highlight the need for a more nuanced investigation 
of how micro-, meso- and macro-level factors intersect to 
influence HIV testing uptake.
Few studies assessed frequencies of collecting test results 
or compared them with testing frequencies. The outcome 
most frequently assessed was “ever in life” testing although 
this outcome measure fails to capture the frequency of HIV 
testing. Furthermore, the highest percentage of recently 
tested FSWs was reported by a Canadian study and con-
stituted 76.1%, an outcome too low to meet either WHO 
recommendations [3, 57] or the “90-90-90” target [1], which 
highlights necessity to increase efforts to promote HIV test-
ing amongst FSWs. Taken together, our results suggest 
addressing simultaneously several outcome measures when 
assessing HIV testing programs among female sex workers, 
including accessibility of testing, willingness to be tested, 
regularity and collecting test results.
In line with previous studies of HIV testing behavior of 
different populations [14, 58, 59], we found that scarcity of 
financial resources, low perceived risk and poor HIV knowl-
edge were barriers to HIV testing for FSWs.
Similar to the results reported for female migrants [58], 
we observed an association between having children and 
HIV testing uptake. This might be manifestation of wom-
en’s and particularly pregnant women’s greater exposure to 
HIV testing, as an offer of HIV testing became generally 
the norm in reproductive and antenatal care settings [3, 60]. 
On the other hand, several papers reviewed suggested that 
women in permanent relationships and with children might 
have higher motivation to stay healthy and thus, might seek 
out testing themselves. For example, in Vietnam, FSWs in 
permanent relationships were more likely to be tested in the 
year 2000 before HIV testing became widely implemented 
as a part of national antenatal health care program across 
the country [61]. Overall, social support from family, peers, 
sex work managers and healthcare workers are instrumen-
tal for promoting HIV testing uptake among FSWs, yet 
the same sources might contribute to further stigma and 
discrimination.
We did not find any consistent associations between age 
of participants [58] or their educational level [58, 59] and 
HIV testing, but working in the sex industry for a longer 
period and starting sex work at older ages were associated 
with higher HIV testing uptake. These findings suggest that 
the willingness to test for HIV might increase with time and 
relate closely with HIV risk awareness.
The inconsistency of results on how condom use and 
number of clients influenced testing might be explained by 
FSWs’ engagement in different types of concurrent sexual 
partnerships. While using condoms with commercial clients 
might be perceived as prevailing acceptable behavior [62], 
the decision to use a condom in cohabiting relationships or 
with a husband might be influenced by interpersonal fac-
tors related to partnership intimacy (e.g., trust, emotional 
closeness, power or reproductive desires) [63]. Moreover, 
there is a need to account not only for the type of partner-
ships, but also for their duration. Consistency of condom use 
might decrease with longer duration of relationships with 
non-paying partners [63], but may increase with commercial 
permanent partners [64]. The relationship intimacy may be 
at play in the HIV testing decision-making process among 
FSWs and for consistent condom use. Testing behavior 
might be influenced by increased trust, emotional closeness 
and familiarity. A more nuanced understanding of how HIV 
testing behavior is influenced by risky sexual behaviors in 
different types of partnerships and how it changes over time 
is needed. In turn, relationship power might be an important 
modifiable factor, which might be considered when develop-
ing HIV testing interventions for FSWs.
The inconsistencies between results in relation to sexual/
drug use behavior and HIV testing might be due to differ-
ences in targets of HIV testing approaches across countries. 
For example, in Canada efforts were concentrated on reach-
ing street-based sex workers and those injecting drugs, 
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leaving out those working indoors, in more high-income 
venues. Nevertheless, at that time sex work was fully decrim-
inalized in Canada [65]. In contrast, in Uzbekistan and Rus-
sia HIV testing might be less accessible for sex workers and 
drug users because of punitive laws. In these countries, HIV 
testing is provided solely through government-affiliated set-
tings, including so-called “friendly cabinets” and thus, sex 
workers and drug users might avoid state clinics or at least 
avoid disclosing who they are, as they might be stigmatized 
by healthcare providers or even arrested. Our results demon-
strate how laws might diminish promising health-promoting 
interventions in some countries while in others, supporting 
policies and concentrated efforts might lead to the successful 
enrolment of most vulnerable populations.
Furthermore, factors, such as violations of human rights 
when forcing FSWs to test, lack of confidentiality and ano-
nymity, discriminatory attitudes of healthcare workers, fear 
of testing HIV+ and being identified as a sex worker and/or 
a drug user, are manifestations of prevailing stigma. Unfor-
tunately, there are still cases where the violation of basic 
human rights is “justified” and sex workers are perceived 
as victims and objects of pity, who should be helped when 
applying mandatory or forced testing. Our findings highlight 
the importance to tackle overlapping stigma and discrimi-
nation across all three levels of SEM in order to promote 
HIV testing among sex workers [66]. This is in line with 
the WHO’s call to enforce the 5 Cs principles and to institu-
tionalize policies preventing discrimination and promoting 
tolerance towards sex workers and people living with HIV 
[61, 67]. As reported before, introduction of discriminative 
laws and policies criminalizing sex work and/or HIV trans-
mission may fuel stigma [65, 68–70].
This review has several limitations. It is restricted to stud-
ies published in English, but only three pre-selected studies 
were excluded for this reason, so the impact upon the find-
ings is likely to be minimal. We included studies published 
during the last 17 years to account for recent HIV testing 
approaches. It is unlikely that the content of previously pub-
lished articles would have substantially altered our findings, 
as rapid HIV testing started in the early 2000s. We excluded 
eight citations with neither abstract, nor title available. We 
acknowledge that our findings are based on the topics pre-
sented by the selected studies, and thus, are restricted by 
the reported information. Despite the limitations mentioned 
above, this study provides a broad overview of the differ-
ent aspects of HIV testing across the global SEM, provides 
important insights on how HIV testing uptake could be 
promoted among FSWs, and suggests avenues for further 
research.
Conclusion
The consistent finding that social support facilitated HIV 
testing calls for the inclusion of meso- level factors into cur-
rent HIV testing strategies directed at FSW. Studies on the 
role of macro-level factors and their intersections with the 
meso and micro levels are needed to inform interventions 
that facilitate HIV testing uptake amongst FSWs.
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Annex 1: Search Strategy
HIV (human Immu-
nodeficiency virus)
(AND combined 
with)
HIV testing/test/
tested
(AND combined 
with)
Sex work
(AND combined with)
OR acquired immu-
nodeficiency syn-
drome OR AIDS
OR voluntary coun-
selling and testing 
OR VCT
OR people who sell 
sex
OR HIV
OR human immuno-
deficiency virus
OR provider initiated 
testing and coun-
selling OR PITC
OR sex industry/sex 
business
OR provider initiated 
counselling and 
testing OR PICT
OR prostitution
OR diagnostic/diag-
nosed
OR FSW OR female 
sex workers
OR screening/
screened
OR CSW OR com-
mercial sex workers
OR routine testing, 
Opt-In, Opt-Out
OR sex services
OR positive result OR escort services
OR testing and coun-
selling OR HTC
OR paid sex
OR transactional sex
The final search strategy was defined as:
(1) Search terms for HIV;
(2) Search term for Sex workers;
(3) Search term for HIV testing;
(4) 1 AND 2 AND 3.
Date of search: 03/November/2017;
Searched fields: abstract, key words, subject headings, 
title;
Databases searched:
Results: Ovid MEDLINE(R)-1,877studies
Embase-2516 studies
SCOPUS-2591 studies
 1. HIV.ab,kw,sh,ti.
 2. AIDS.ab,kw,sh,ti.
 3. Human Immunodeficiency virus.ab,kw,sh,ti.
 4. Acquired Immunodeficiency syndrome.ab,kw,sh,ti.
 5. 1 or 2 or 3 or 4
 6. “test* “.ab,kw,sh,ti.
 7. “counsel* “.ab,kw,sh,ti.
 8. HTC.ab,kw,sh,ti.
 9. VCT.ab,kw,sh,ti.
 10. (Voluntary counsel* and test*).ab,kw,sh,ti.
 11. (Provider Initiated test* and counsel*).ab,kw,sh,ti.
 12. PITC.ab,kw,sh,ti.
 13. PICT.ab,kw,sh,ti.
 14. (Provider Initiated counsel* and test*).ab,kw,sh,ti.
 15. “diagnos* “.ab,kw,sh,ti.
 16. “screen* “.ab,kw,sh,ti.
 17. “Routine test* “.ab,kw,sh,ti.
 18. Opt-In.ab,kw,sh,ti.
 19. OPt-Out.ab,kw,sh,ti.
 20. Positive results.ab,kw,sh,ti.
 21. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 
16 or 17 or 18 or 19 or 20
 22. “Sex* work* “.ab,kw,sh,ti.
 23. “people who sell sex* “.ab,kw,sh,ti.
 24. “sex* industry “.ab,kw,sh,ti.
 25. “sex* business “.ab,kw,sh,ti.
 26. “sex* service* “.ab,kw,sh,ti.
 27. “prostitut* “.ab,kw,sh,ti.
 28. “female sex* work* “.ab,kw,sh,ti.
 29. “commercial sex* work* “.ab,kw,sh,ti.
 30. “Escort* service* “.ab,kw,sh,ti.
 31. “paid sex* “.ab,kw,sh,ti.
 32. “transactional sex* “.ab,kw,sh,ti.
 33. “FSW* “.ab,kw,sh,ti.
 34. “CSW* “.ab,kw,sh,ti.
 35. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 
or 32 or 33 or 34
 36. 5 and 21 and 35
 37. (“2000” or “2001” or “2002” or “2003” or “2004” or 
“2005” or “2006” or “2007” or “2008” or “2009” or 
“2010” or “2011” or “2012” or “2013” or “2014” or 
“2015” or “2016” or “2017”).yr.
 38. 36 and 37
Annex 2: Data Extraction Form
Title
Date published
Date of research
Authors
Study design
Research objectives/
research questions
Country
Study population
Main methods of research
Main results
Main conclusions
Comments*(if needed)
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Annex 3: Quality Assessment
The quality of the qualitative papers (Table 1) was assessed 
using the guide for critically appraising qualitative research 
[15].The checklist consisted of 18 items assessing findings, 
design, sample, data collection, analysis, reporting, reflex-
ivity and neutrality, ethics and auditability. As in previous 
research [66] we used a midpoint score of 9 as a cut off 
between low- and high-quality studies.
We assessed the quality of the quantitative and mixed-
methods papers using the modified Downs and Black check-
list [16]. The 26 questions of the checklist represented items 
of reporting, external and internal validity, and power. As 
the majority of studies did not report power calculations of 
the sample size and none was single or double blinded, we 
excluded the power (#27) and the blinding (#13, 14) ques-
tions. Thus, the modified checklist consisted of 24 questions 
with a maximum score of 25 points). A midpoint score of 
12.5 was considered to distinguish the high-quality studies 
(Table 2).
Table 2  Quality assessment of the 36 studies
Study reference Study design Summary score for 
quality assessment
Qualitative methods (Spencer et al. [15])
 Ameyan et al. [47] QL 61% (11/18)
 Beattie et al. [48] QL 72% (13/18)
 Burke et al. [54] QL 61% (11/18)
 Chanda et al. [49] QL 67% (12/18)
 Dugas et al. [29] QL 50% (9/18)
 King et al. [46] QL 50% (9/18)
 Ngo et al. [50] QL 72% (13/18)
 Scorgie et al. [52] QL 67% (12/18)
 Wang et al. [41] QL 67% (12/18)
 Wanyenze et al. 
[51]
QL 72% (13/18)
Quantitative methods (modified Downs and Black [16])
 Batona et al. [28] QN 56% (14/25)
 Bengtson et al. [27] QN 52% (13/25)
 Chiao et al. [45] QN 72% (18/25)
 Dandona et al. [18] QN 40% (10/25)
 Deering et al. [25] QN 60% (15/25)
 Grayman et al. [30] QN 48% (12/25)
 Hong et al. [31] QN 52% (13/25)
 Johnston et al. [40] QN 64% (16/25)
 King et al. [46] QN 52% (13/25)
 Nhurod et al. [43] QN 56% (14/25)
 Parriault et al. [17] QN 36% (9/25)
 Shokoohi et al. [35] QN 56% (14/25)
 Shokoohi et al. [35] QN 60% (15/25)
 Todd et al. [32] QN 52% (13/25)
 Tran et al. [33] QN 52% (13/25)
Study reference Study design Summary score for 
quality assessment
 Wang et al. [19] QN 48% (12/25)
 Wang et al. [20] QN 48% (12/25)
 Wilson et al. [21] QN, mathematical 
modeling
n/a
 Xun et al. [42] QN 56% (14/25)
 Xu et al. [23] QN 64% (16/25)
Mixed methods (modified Downs and Black [16])
 Aho et al. [26] QN & QL 68% (17/25)
 King et al. [34] QN & QL 48 (12/25)
Abstracts
 Deering et al. [37] QN n/a
 Park et al. [38] QN n/a
 Sayarifard et al. 
[36]
QN n/a
 Simonovikj et al. 
[53]
Case report n/a
Table 2  continued
 AIDS and Behavior
1 3
Annex 4: PRISMA 2009 checklist
Section/topic # Checklist item Reported (Yes/No)
Title
 Title 1 Identify the report as a systematic review, meta-analysis, or both. Yes
Abstract
 Structured summary 2 Provide a structured summary including, as applicable: background; objectives; 
data sources; study eligibility criteria, participants, and interventions; study 
appraisal and synthesis methods; results; limitations; conclusions and impli-
cations of key findings; systematic review registration number.
Yes
Introduction
 Rationale 3 Describe the rationale for the review in the context of what is already known. Yes
 Objectives 4 Provide an explicit statement of questions being addressed with reference 
to participants, interventions, comparisons, outcomes, and study design 
(PICOS).
Not applicable
Methods
 Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including registra-
tion number.
Not available
 Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as 
criteria for eligibility, giving rationale.
Yes
 Information sources 7 Describe all information sources (e.g., databases with dates of coverage, con-
tact with study authors to identify additional studies) in the search and date 
last searched.
Yes
 Search 8 Present full electronic search strategy for at least one database, including any 
limits used, such that it could be repeated.
Yes (“Annex 1: Search 
strategy”)
 Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in 
systematic review, and, if applicable, included in the meta-analysis).
Yes (Fig. 1)
 Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, indepen-
dently, in duplicate) and any processes for obtaining and confirming data 
from investigators.
Yes (“Annex 2: Data 
extraction form”)
 Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made.
Yes
 Risk of bias in individual 
studies
12 Describe methods used for assessing risk of bias of individual studies (includ-
ing specification of whether this was done at the study or outcome level), and 
how this information is to be used in any data synthesis.
Not available
 Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). Yes
 Synthesis of results 14 Describe the methods of handling data and combining results of studies, if 
done, including measures of consistency (e.g.,  I2) for each meta-analysis.
Not applicable
 Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence 
(e.g., publication bias, selective reporting within studies).
Yes
 Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, 
meta-regression), if done, indicating which were pre-specified.
Not available
Results
 Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the 
review, with reasons for exclusions at each stage, ideally with a flow diagram.
Yes (Fig. 1)
 Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study 
size, PICOS, follow-up period) and provide the citations.
Yes (Table 1)
 Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level 
assessment (see item 12).
Not available
 Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) 
simple summary data for each intervention group (b) effect estimates and 
confidence intervals, ideally with a forest plot.
Not applicable
 Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and 
measures of consistency.
Not applicable
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